Headline
The latest news stories.
The Wisconsin Department of Health Services reported Nov. 5 that an infant died of measles, marking the first measles-associated death in the state since 1990.
A study released Nov. 5 by the National Institutes of Health found that women with higher blood levels of two common per- and polyfluoroalkyl substances, or PFAS, have a higher risk of developing an aggressive form of breast cancer.
The Centers for Medicare & Medicaid Services Nov. 5 proposed changes to Medicare’s Conditions of Participation and other administrative requirements that are intended to remove or revise obsolete, outdated and excessively burdensome regulations for hospitals and other healthcare providers.
The Centers for Medicare & Medicaid Services Nov. 5 published a final rule to codify the Medicare Drug Price Negotiation Program beginning in 2029.
Federal agencies Nov. 5 issued a bulletin saying that they are aware of malicious cyber activity targeting industrial refrigeration and cold chain monitoring systems globally, including systems used within the healthcare sector.
The U.S. District Court for the Eastern District of Pennsylvania Nov. 4 ruled in favor of Jefferson Health in granting a public resolution to determine the legality of Aetna’s “level of severity” reimbursement policy.
The departments of Labor, Health and Human Services, and the Treasury announced yesterday the denial of the recertification of two entities currently participating in the federal independent dispute resolution process under the No Surprises Act. The agencies determined that Island Peer Review…
Christine Moutier, M.D., chief medical officer at the American Foundation for Suicide Prevention, discusses the usage of artificial intelligence chatbots among adolescents, the potential dangers for young people experiencing mental health challenges, and the importance of educating clinicians and…
Early registration rates for the 2027 AHA Rural Healthcare Leadership Conference end Dec. 1.
The estimated average monthly premium for Medicare Part D stand-alone prescription drug plans is $51 for 2027, a 50% increase from $34 in 2026, for enrollees that continue on the same plans, according to a KFF analysis released Oct. 30. Monthly premiums for Medicare Advantage prescription drug…